Literature DB >> 15489924

[Retrospective analysis of 1905 patients with skin cancer from two general hospitals in western China from 1981 to 2000].

Tian-wen Gao1, Dong-jie Sun, Chun-ying Li, Hong He, Qing Li, You-sheng Liu, Qing-chun Diao, Gao-sheng Huang, Fei Hao, Bai-yu Zhong, Fu-cheng Ma, Feng-xuan Liu, Xiao-chu Yan, Dong-mei Liu, Yu-feng Liu, Rong-qing Liu.   

Abstract

OBJECTIVE: To investigate the clinical features and changes in the incidence of skin cancer in two hospitals located in western China.
METHODS: The patients diagnosed pathologically as skin cancer from 1981 to 2000 were retrospectively collected from the two hospitals. Clinical data of patients with skin cancer were collected and analyzed.
RESULTS: (1) Of the 1 905 patients with skin cancer, squamous cell carcinoma accounted for 29.4%(560 patients), basal cell carcinoma 28.0% (534), and cutaneous malignant melanoma(CMM) 16.0% (305). (2) There were 591 patients with skin cancer diagnosed between 1980 and 1990, and 1 314 between 1991 and 2000, and accounted for 0.34% and 0.58% of all biopsy cases, respectively. The number of total biopsy patients increased 1.6% every year during the 20 years. The number of biopsy patients with skin cancer and with CMM increased 3.5% and 3.9% every year,respectively. (3) Of the 305 CMM patients, 63.3% located on the acra. These patients were elder, and have a higher rate of trauma and a higher incidence in the male than that in patients with CMM located on the other sites. (4) Of the 305 CMM patients, 64 (21%) had history of trauma at the primary onset sites, and 47 (15.4%) had history of small congenital nevi at the primary sites.
CONCLUSION: There are some differences in the clinical features such as location and age between the skin cancer patients in our study and those in white population. The incidence of skin cancer in the two hospitals had been increasing in the 20 years (between 1981 and 2000). Both trauma and small congenital nevi are important risk factors of CMM.

Entities:  

Mesh:

Year:  2004        PMID: 15489924

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  5 in total

1.  MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.

Authors:  Jianda Zhou; Rui Liu; Chengqun Luo; Xiao Zhou; Kun Xia; Xiang Chen; Ming Zhou; Qiong Zou; Peiguo Cao; Ke Cao
Journal:  Cancer Biol Ther       Date:  2014-07-14       Impact factor: 4.742

2.  Clinical Characteristics of Malignant Melanoma in Southwest China: A Single-Center Series of 82 Consecutive Cases and a Meta-Analysis of 958 Reported Cases.

Authors:  Jia Yu; Xue Luo; Hui Huang; Zhifang Zhai; Zhu Shen; Hui Lin
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

3.  Clinical and Demographic Profile of Cutaneous Melanoma: Pakistani Perspective.

Authors:  Muhammad Saaiq; Saad Siddiqui
Journal:  World J Plast Surg       Date:  2020-09

4.  Overall Survival of Patients With Unresectable or Metastatic BRAF V600-Mutant Acral/Cutaneous Melanoma Administered Dabrafenib Plus Trametinib: Long-Term Follow-Up of a Multicenter, Single-Arm Phase IIa Trial.

Authors:  Lili Mao; Ya Ding; Xue Bai; Xinan Sheng; Jie Dai; Zhihong Chi; Chuanliang Cui; Yan Kong; Yun Fan; Yanjun Xu; Xuan Wang; Bixia Tang; Bin Lian; Xieqiao Yan; Siming Li; Li Zhou; Xiaoting Wei; Caili Li; Jun Guo; Xiaoshi Zhang; Lu Si
Journal:  Front Oncol       Date:  2021-08-24       Impact factor: 6.244

5.  Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.

Authors:  Yi-Shuan Sheen; Yi-Hua Liao; Ming-Hsien Lin; Hsien-Ching Chiu; Shiou-Hwa Jee; Jau-Yu Liau; Yih-Leong Chang; Chia-Yu Chu
Journal:  PLoS One       Date:  2016-01-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.